University Of Strasbourg is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Strasbourg is a public research university located in Strasbourg, France. Founded in 1621, it is one of Europe's oldest and most prestigious universities. The university has a strong tradition in life sciences and biomedical research, particularly in neuroscience and neurodegeneration.
The University of Strasbourg traces its origins to the Jesuit gymnasium established in 1538, making it one of Europe's oldest universities. The current institution was formed in 2009 through the merger of three previous universities (Strasbourg I, II, and III), creating one of France's largest and most prestigious research universities with approximately 56,000 students.
Strasbourg has been a major center for neuroscience research since the late 19th century. The city was home to Nobel Prize winners including Ali Bavois, whose work on light-sensitive proteins laid groundwork for optogenetics, and Jean-Marie Lehn, whose contributions to supramolecular chemistry have applications in understanding protein aggregation in neurodegenerative diseases.
The university hosts several world-class research facilities:
The University of Strasbourg is internationally recognized for prion disease research. The team led by Inga Zerr and colleagues conducts pioneering work on sporadic and genetic Creutzfeldt-Jakob disease, including early diagnosis, biomarker discovery, and therapeutic trials.
The university-affiliated hospitals conduct numerous clinical trials for neurodegenerative diseases, particularly in Alzheimer's disease (with connections to the European ADNI consortium) and Parkinson's disease (deep brain stimulation trials).
The university maintains research partnerships with:
Research Focus
| Area | Focus | Collaborations |
|---|---|---|
| Prion Research | PrP misfolding, Creutzfeldt-Jakob disease | Robert Will, Inga Zerr |
| Neuroimaging | MRI, PET for AD/PD | Strasbourg NeuroCampus |
| Stem Cells | iPSC models of neurodegeneration | INSERM |
The study of University Of Strasbourg has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.